跳至主要内容
临床试验/JPRN-UMIN000032134
JPRN-UMIN000032134尚未招募未知

Safety and effectiveness of autologous leukocyte-rich platelet-rich plasma therapy (L-PRP therapy) for damage, deficit and prolonged healing in the musculoskeletal system of the human body - Safety and effectiveness of autologous leukocyte-rich platelet-rich plasma therapy (L-PRP therapy)

Jikei University Orthopedic0 个研究点目标入组 5 人开始时间: 2018年4月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with bacterial infections in the whole body or in areas undergoing this treatment Patients who are suggestive of the possibility of affecting the general condition when infection is caused by this therapy Patients who have a fever of 37 degrees or more without using antipyretics or anti-inflammatory analgesics Patients with open wounds Patients during oral treatment

研究者

发起方
Jikei University Orthopedic

相似试验